Presented by: William Sauve, MD

This course will help attendees understand the risks and benefits of TMS Therapy. It will explain why changes to current pharmacotherapy may be necessary prior to the administration of TMS therapy. We will discuss the difference between the FDA’s indication and the insurance companies medical necessity criteria. Lastly, we will determine which patient populations may benefit most, and which precautions should be taken with certain subsets. 

Once you have purchased this webinar, you will be emailed a downloadable attachment. That download will have a link and instructions for how to view the webinar, take the quiz, and get your CE certificate.

Please read those instructions closely.

There are no refunds for CE Certificates.